Nurix Therapeutics, Inc. — Form D
Nurix Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-26. The offering totals $120.2M, of which $120.2M was reported sold. Industry: Other.
Offering
- Filed: 2020-03-26
- Form: D
- Accession: 0001549595-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $120.2M
- Amount sold: $120.2M
- Investors: 23
- Date of first sale: 2020-03-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-363761
Issuer
- Name: Nurix Therapeutics, Inc.
- CIK: 0001549595
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1700 OWENS STREET, SUITE 205, SAN FRANCISCO, CA, 94158
- Phone: (415) 660-5320
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Leon Chen | Director | Austin, TX |
| Julia Gregory | Director | South San Francisco, CA |
| Lori Kunkel | Director | San Francisco, CA |
| David Lacey | Director | San Francisco, CA |
| Arthur Sands | Director | San Francisco, CA |
| Robert Tjian | Director | South San Francisco, CA |
| Jeff Tong | Director | San Francisco, CA |
| Christine Ring | Executive Officer | San Francisco, CA |
| Arthur Sands | Executive Officer | San Francisco, CA |
| Hans van Houte | Executive Officer | San Francisco, CA |
| David Goeddel | Director | Agoura Hills, CA |
| Mark Goldsmith | Director | Burlingame, CA |
| Mark Goldsmith | Executive Officer | Burlingame, CA |
| Timothy Kutzkey | Director | San Francisco, CA |
| Timothy Kutzkey | Executive Officer | San Francisco, CA |
| Kutzkey Timothy | Director | San Francisco, CA |
| Kutzkey Timothy | Executive Officer | San Francisco, CA |
| Arthur T Sands | Director | The Woodlands, TX |
| Arthur T Sands | Executive Officer | The Woodlands, TX |
Other filings by this issuer (5)
More